About this trial
This is a prospective, interventional study aiming to develop and validate an ultrasound training program for gynecology and obstetrics residents, focused on the staging of gynecologic cancers, including ovarian, endometrial, and cervical cancer. The program consists of theoretical lectures, practical hands-on sessions, and supervised clinical case evaluations over a six-month period. Residents will perform ultrasound examinations independently, which will be compared to those conducted by expert sonographers. The primary objective is to assess the learning curve of each trainee by evaluating diagnostic concordance with expert findings across specific staging parameters.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
At least six gynecology residents who will regularly attend the ultrasound center daily, with overlapping shifts.
All patients with a diagnosis or suspected diagnosis of gynecological cancer, including ovarian, endometrial, and cervical cancers, will be included in the study and scanned by both residents and experts.
Signing of the informed consent by the participants.
Disqualifiers
non-gynecology specialists, with attendance schedules at the center other than daily.
Failure to sign the informed consent by the participants.
Trial design
Single group
Treatments tested in this trial
Training Group
BehavioralA structured educational and practical training program in gynecologic oncology ultrasound designed for residents. The intervention includes lectures, clinical case discussions, supervised and independent ultrasound examinations, and performance assessments to evaluate learning progression and diagnostic concordance with experts.
Treatment groups
Trial outcomes
Primary outcomes
Agreement Rate Between Residents and Experts in Ultrasound-Based Staging of Gynecologic Cancers
Assessment of the diagnostic concordance between ultrasound staging performed by residents and expert sonographers, measured across defined anatomical and pathological parameters (e.g., lymph node involvement, carcinomatosis, tumor size and spread). Concordance will be quantified as the percentage of agreement per case and per parameter.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: